The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)

Amanda L Tauber; Stephanie S Schweiker; Stephan M Levonis

doi:10.4155/fmc-2020-0226

The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)

Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis

Faculty of Health Sciences & Medicine

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Understanding the potential association between the poly (ADP-ribose) polymerase member 14 (PARP14) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may aid in understanding the host immunopathological response to the virus. PARP14 has an emerging role in viral infections, and this article considers its potential mechanisms for action in either a pro- or anti-viral manner. It is evident that more experimental work is required; however, PARP14 appears vital in controlling the interferon response to the SARS-CoV-2 infection and has potential roles in balancing the proinflammatory cytokines of the cytokine storm. Furthermore, the SARS-CoV-2 macrodomain can prevent the PARP14-mediated antiviral response, suggesting a more complex relationship between PARP14 activity and SARS-CoV-2 infections.

Original language	English
Pages (from-to)	587-592
Number of pages	6
Journal	Future Medicinal Chemistry
Volume	13
Issue number	6
Early online date	20 Jan 2021
DOIs	https://doi.org/10.4155/fmc-2020-0226
Publication status	Published - Mar 2021

Access to Document

10.4155/fmc-2020-0226Licence: Free to read

Link to publication in Scopus

Fingerprint Dive into the research topics of 'The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)'. Together they form a unique fingerprint.

Cite this

@article{7cf5b3bdf2ec4a91925cfe7d8de84a5d,

title = "The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)",

abstract = "Understanding the potential association between the poly (ADP-ribose) polymerase member 14 (PARP14) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may aid in understanding the host immunopathological response to the virus. PARP14 has an emerging role in viral infections, and this article considers its potential mechanisms for action in either a pro- or anti-viral manner. It is evident that more experimental work is required; however, PARP14 appears vital in controlling the interferon response to the SARS-CoV-2 infection and has potential roles in balancing the proinflammatory cytokines of the cytokine storm. Furthermore, the SARS-CoV-2 macrodomain can prevent the PARP14-mediated antiviral response, suggesting a more complex relationship between PARP14 activity and SARS-CoV-2 infections.",

author = "Tauber, {Amanda L} and Schweiker, {Stephanie S} and Levonis, {Stephan M}",

year = "2021",

month = mar,

doi = "10.4155/fmc-2020-0226",

language = "English",

volume = "13",

pages = "587--592",

journal = "Future Medicinal Chemistry",

issn = "1756-8927",

publisher = "Future Science",

number = "6",

}

TY - JOUR

T1 - The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)

AU - Tauber, Amanda L

AU - Schweiker, Stephanie S

AU - Levonis, Stephan M

PY - 2021/3

Y1 - 2021/3

N2 - Understanding the potential association between the poly (ADP-ribose) polymerase member 14 (PARP14) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may aid in understanding the host immunopathological response to the virus. PARP14 has an emerging role in viral infections, and this article considers its potential mechanisms for action in either a pro- or anti-viral manner. It is evident that more experimental work is required; however, PARP14 appears vital in controlling the interferon response to the SARS-CoV-2 infection and has potential roles in balancing the proinflammatory cytokines of the cytokine storm. Furthermore, the SARS-CoV-2 macrodomain can prevent the PARP14-mediated antiviral response, suggesting a more complex relationship between PARP14 activity and SARS-CoV-2 infections.

AB - Understanding the potential association between the poly (ADP-ribose) polymerase member 14 (PARP14) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may aid in understanding the host immunopathological response to the virus. PARP14 has an emerging role in viral infections, and this article considers its potential mechanisms for action in either a pro- or anti-viral manner. It is evident that more experimental work is required; however, PARP14 appears vital in controlling the interferon response to the SARS-CoV-2 infection and has potential roles in balancing the proinflammatory cytokines of the cytokine storm. Furthermore, the SARS-CoV-2 macrodomain can prevent the PARP14-mediated antiviral response, suggesting a more complex relationship between PARP14 activity and SARS-CoV-2 infections.

UR - http://www.scopus.com/inward/record.url?scp=85102589353&partnerID=8YFLogxK

U2 - 10.4155/fmc-2020-0226

DO - 10.4155/fmc-2020-0226

M3 - Article

C2 - 33467912

VL - 13

SP - 587

EP - 592

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8927

IS - 6

ER -